| Document |
Document Title |
|
WO/2011/043272 |
Disclosed are: a ligand for an asymmetric synthesis catalyst; and a process for producing an α-alkenyl cyclic compound using the ligand. Specifically disclosed are: a ligand for an asymmetric synthesis catalyst, which is represented by ...
|
|
WO/2011/043660 |
The application describes a method for the preparation of 2,5-furandicarboxylic acid ("FDCA") and/or an alkyl ester of FDCA comprising the step of contacting a feed comprising a starting material selected from 5-alkoxymethylfurfural, 2,5...
|
|
WO/2011/043661 |
The application describes a method for the preparation of 2,5-furan dicarboxylic acid comprising the step of contacting a feed comprising a compound selected from the group consisting of 5-hydroxymethylfurfural ("HMF"), an ester of 5-hyd...
|
|
WO/2011/037192 |
Disclosed is a substituted amide represented by formula (I), which is useful as an active ingredient of a pharmaceutical composition, especially as an active ingredient of a pharmaceutical composition for the treatment of diseases that a...
|
|
WO/2011/035445 |
Novel polymeric rhodium catalysts having repeating subunits of Formula (I), wherein R1-R8, X, A, m, n and p are as defined in the application, are described along with methods of using these catalysts, as well as precursors therefor, in ...
|
|
WO/2011/034118 |
Since a polymerizable liquid crystal compound represented by the general formula (1) produces polymers exhibiting high optical anisotropy and high chemical resistance, and the optical anisotropy thereof exhibits low wavelength dependence...
|
|
WO/2011/031023 |
The present invention relates to a method for producing cyclicised compounds, and more specifically lactone compounds and heterocyclic compounds comprising oxygen, in high yield, with long-term stability and with high selectivity dependi...
|
|
WO/2011/031023 |
The present invention relates to a method for producing cyclicised compounds, and more specifically lactone compounds and heterocyclic compounds comprising oxygen, in high yield, with long-term stability and with high selectivity dependi...
|
|
WO/2011/031764 |
Described herein are compounds of formula (I), related compositions, and their use, for example in the formation of α-amino acids or a precursor thereof such as an α-aminonitrile.
|
|
WO/2011/030881 |
A furan derivative represented by the following General Formula (1): where Ar1 and Ar2 each independently represent an aryl group which may have a substituent, and R1 represents a C1-C6 alkylene group.
|
|
WO/2011/028927 |
Described herein are compounds of the formula useful as antagonists of sphingosine-1- phosphate receptors. Further described herein is the use of these compounds and related pharmaceutical compositions to treat disorders associated with ...
|
|
WO/2011/028781 |
Provided are methods of treating a disease or condition caused by or associated with a virus belonging to the Poxviridae family using iminosugars, such as DNJ derivatives.
|
|
WO/2011/027323 |
The present invention relates to a process for the preparation of ramelteon using 2- [(8S)-1, 6,7, 8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethanamine of Formula I or a salt thereof as an intermediate.
|
|
WO/2011/027319 |
The present invention relates to a process for the preparation of (2E)- 1,2,6,7- tetrahydro-8H-indeno[5,4-b]furan-8-ylideneethanenitrile of Formula (I). The present invention further relates to a process for the preparation of ramelteon ...
|
|
WO/2011/026701 |
The invention relates to a polycondensation product on the basis of aromatics and/or heteroaromatics and aldehydes, wherein said product contains at least one structural unit (I) comprising one polyisobutylene side chain and an aromatic ...
|
|
WO/2011/026913 |
The invention relates to a polypeptide having oxidoreductase activity which comprises the amino acid sequence set out in SEQ ID NO: 3 or an amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 4, or a variant polypeptide ...
|
|
WO/2011/026959 |
The invention relates to novel hepcidin antagonists of formula (I), to pharmaceutical compositions containing same, and to the use thereof as a medicament, especially for treating iron metabolism disorders such as especially iron deficie...
|
|
WO/2011/027888 |
Disclosed are a diamide-phenyl derivative which inhibits soluble epoxy hydrolase (sEH), and a pharmaceutically acceptable salt of the diamide-phenyl derivative. Specifically disclosed are a compound represented by formula (I), and a phar...
|
|
WO/2011/024171 |
This invention is directed to oligofurans, process of preparation and uses thereof.
|
|
WO/2011/023491 |
The invention relates to mixtures of isodecyl furan-2,5-dicarboxylate of formula I, methods for producing said mixtures of isodecyl furan-2,5-dicarboxylate of formula I, compositions containing mixtures of isodecyl furan-2,5-dicarboxylat...
|
|
WO/2011/025982 |
The present invention is directed to a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composi...
|
|
WO/2011/026061 |
A process is provided for the synthesis of furan and related compounds by vapor-phase decarbonylation of furfural and derivatives, using a palladium/metal aluminate catalyst that has been promoted with an alkali carbonate, such as cesium...
|
|
WO/2011/023590 |
The invention relates to mixtures of isononyl furan-2,5-dicarboxylate of formula (I), methods for producing said mixtures of isononyl furan-2,5-dicarboxylate of formula (I), compositions containing mixtures of isononyl furan-2,5-dicarbox...
|
|
WO/2011/022781 |
The present invention relates generally to methods for treating macular degeneration, and in particular age-related macular degeneration, involving the use of specific benzofuran based compounds.
|
|
WO/2011/023667 |
The present invention relates to the use of a compound of general formula (I) wherein R1/R2 are independently from each other hydrogen, lower alkyl, -CH2)o-cycloalkyl for o being 0 or 1, or are benzyl or heterocycloalkyl; or R1 and R2 ar...
|
|
WO/2011/026063 |
A process is provided for the synthesis of furan and related compounds by liquid-phase decarbonylation of furfural and derivatives, using a palladium/metal aluminate catalyst. The compounds so produced can be used as starting materials f...
|
|
WO/2011/026059 |
A process is provided for the synthesis of furan and related compounds by vapor-phase decarbonylation of furfural and derivatives, using a palladium/metal aluminate catalyst. The use of such catalysts, which are inherently less acidic th...
|
|
WO/2011/026153 |
Optimal compositions of derivatives of 5-methyl-3(2H)-furanone compounds and phenylpropanoid polyketides related to inotilone, that exert biological response modification in health and disease, and their method of preparation, are disclo...
|
|
WO/2011/022450 |
Described herein are methods for synthesizing 1-aryl-2-tetralones in an efficient and highly selective manner. The reaction involves a one-step procedure for coupling an aryl halide to a 2-tetralone, where coupling occurs substantially a...
|
|
WO/2011/021520 |
Provided are organic electroluminescent (EL) element materials which can lower the driving voltage of an organic EL element in comparison to conventional organic EL element materials and which can lengthen the life of the EL element, mor...
|
|
WO/2011/022511 |
Provided herein is a method of reducing purified lignin. Further disclosed herein are aromatic and non-aromatic compounds obtained from reduced lignin.
|
|
WO/2011/022679 |
Furanopyridine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.
|
|
WO/2011/022511 |
Provided herein is a method of reducing purified lignin. Further disclosed herein are aromatic and non-aromatic compounds obtained from reduced lignin.
|
|
WO/2011/020564 |
The invention relates to a method for producing 4-aminobut-2-enolide compounds of the formula (I), comprising the reaction of a 4-(methylamino)furane-2-(5H)-one compound of the formula (II) with an amine of the formula (III), where R1 an...
|
|
WO/2011/022679 |
Furanopyridine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.
|
|
WO/2011/018180 |
The invention relates to a method for producing 2,4-dioxotetrahydrofurane-3-carboxylates of the formula (I) or (I') comprising the conversion of a halogen acetyl chloride compound of the formula (II) with a malonic acid ester of the form...
|
|
WO/2011/015169 |
The invention relates to a method for continuously producing a mixture of phthalic acid and phthalic anhydride dissolved in an aliphatic monocarboxylic acid, preferably in acetic acid, by means of oxidation of o-xylene dissolved in the m...
|
|
WO/2011/016648 |
Provided are novel organic electroluminescent compounds and an organic electroluminescent device using the same. Since the organic electroluminescent compound disclosed herein exhibits good luminescent efficiency and excellent life prope...
|
|
WO/2011/016050 |
The present invention relates to novel compounds of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvat...
|
|
WO/2011/015645 |
A process for preparing a hydroxyacid or hydroxyester from a reactant selected from (a) a carboxylic acid having an aldehyde or keto group; and (b) an ester of a carboxylic acid having an aldehyde or keto group; by contacting the reactan...
|
|
WO/2011/015101 |
Disclosed is a process for separating 5-hydroxy-4-methyl-2-5[H]-furanone produced by glyoxylic acid and n-propionaldehyde as starting materials, characterized in that the extraction separation is carried out with an organic solvent in th...
|
|
WO/2011/015169 |
The invention relates to a method for continuously producing a mixture of phthalic acid and phthalic anhydride dissolved in an aliphatic monocarboxylic acid, preferably in acetic acid, by means of oxidation of o-xylene dissolved in the m...
|
|
WO/2011/010013 |
The present invention relates to acyl guanidine derivatives modulating the hedgehog protein signaling pathway to be used as drugs, in particular for treating diseases involving a tissue dysfunction associated with a deregulation of the h...
|
|
WO/2011/010496 |
The amount of ultraviolet light that reaches the ground tends to be increasing due to the disruption of the ozone layer or the change in the global environment. When the skin is irradiated with ultraviolet light, tyrosine in the skin is ...
|
|
WO/2011/007722 |
Disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. (In the formula, ring A represents a phenylene or the like; R1 represents an optionally substituted C6-10 aryl group or the like; R2 and ...
|
|
WO/2011/003191 |
Provided are viral sensitizing compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions ...
|
|
WO/2011/003300 |
A method for preparing hydroxymethylfurfural, which comprises: a) mixing and dissolving triose or its derivatives and solvent 1 to obtain the first reaction mixture; b) reacting the obtained first reaction mixture with alkaline catalyst ...
|
|
WO/2011/005505 |
The present invention provides a method for the purification of a prostaglandin by supercritical fluid chromatography, said method comprising the use of a stationary phase and a mobile phase comprising carbon dioxide, provided that when ...
|
|
WO/2011/006080 |
The invention relates to the use of a compound of formula (I); wherein R1 represents a methyl or ethyl group, with the compound being in the form of an edible salt as flavor precursor for generating an ingredient to impart or reinforce t...
|
|
WO/2011/006080 |
The invention relates to the use of a compound of formula (I); wherein R1 represents a methyl or ethyl group, with the compound being in the form of an edible salt as flavor precursor for generating an ingredient to impart or reinforce t...
|
